Russell Fleischer

1.1k total citations
7 papers, 779 citations indexed

About

Russell Fleischer is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Russell Fleischer has authored 7 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Russell Fleischer's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Russell Fleischer is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Russell Fleischer collaborates with scholars based in United States and United Kingdom. Russell Fleischer's co-authors include Anna S. Lok, Jay H. Hoofnagle, T. Jake Liang, Edward Doo, Kenneth E. Sherman, Jeffrey S. Murray, Debra Birnkrant, Thomas Hammerstrom, Pravin Jadhav and Jianmeng Chen and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Russell Fleischer

7 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Russell Fleischer United States	7	693	678	157	32	24	7	779
María Sales Gilabert Spain	2	476 0.7×	534 0.8×	189 1.2×	37 1.2×	52 2.2×	5	624
AM Di Bisceglie United States	5	497 0.7×	574 0.8×	182 1.2×	16 0.5×	23 1.0×	9	631
Uta Naumann Germany	12	578 0.8×	575 0.8×	70 0.4×	36 1.1×	8 0.3×	32	680
Jeanne Serpaggi France	9	697 1.0×	738 1.1×	73 0.5×	17 0.5×	14 0.6×	9	799
Patricia Méndez United States	12	317 0.5×	328 0.5×	129 0.8×	32 1.0×	15 0.6×	25	430
G. Carosi Italy	6	447 0.6×	485 0.7×	79 0.5×	12 0.4×	20 0.8×	9	533
Ana Arizcorreta Spain	7	316 0.5×	382 0.6×	108 0.7×	16 0.5×	49 2.0×	12	428
C. De Bac Italy	11	421 0.6×	424 0.6×	108 0.7×	14 0.4×	27 1.1×	27	542
Josep M. Guardiola Spain	11	273 0.4×	324 0.5×	184 1.2×	20 0.6×	22 0.9×	25	423
Dessislava I. Dimitrova United States	8	588 0.8×	688 1.0×	161 1.0×	67 2.1×	7 0.3×	11	775

Countries citing papers authored by Russell Fleischer

Since Specialization

Citations

This map shows the geographic impact of Russell Fleischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Fleischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Fleischer more than expected).

Fields of papers citing papers by Russell Fleischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Fleischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Fleischer. The network helps show where Russell Fleischer may publish in the future.

Co-authorship network of co-authors of Russell Fleischer

This figure shows the co-authorship network connecting the top 25 collaborators of Russell Fleischer. A scholar is included among the top collaborators of Russell Fleischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Russell Fleischer. Russell Fleischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Harrington, Patrick R., Russell Fleischer, Sarah Connelly, Linda Lewis, & Jeffrey S. Murray. (2015). Ribavirin Reduces Absolute Lymphocyte Counts in Hepatitis C Virus–Infected Patients Treated With Interferon-Free, Direct-Acting Antiviral Regimens: Figure 1.. Clinical Infectious Diseases. 61(6). 974–977. 7 indexed citations

2.

Chen, Jianmeng, Jeffry Florian, Wendy Carter, et al.. (2013). Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies. Gastroenterology. 144(7). 1450–1455.e2. 130 indexed citations

3.

Liu, Jiang, Pravin Jadhav, Shashi Amur, et al.. (2012). Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. Hepatology. 57(3). 897–902. 9 indexed citations

4.

Fleischer, Russell & Anna S. Lok. (2009). Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. Journal of Hepatology. 51(4). 787–791. 57 indexed citations

5.

Hoofnagle, Jay H., Edward Doo, T. Jake Liang, Russell Fleischer, & Anna S. Lok. (2007). Management of hepatitis B. Hepatology. 45(4). 1056–1075. 471 indexed citations

6.

Sherman, Kenneth E., et al.. (2007). Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations. Hepatology. 46(6). 2014–2020. 17 indexed citations

7.

Fleischer, Russell, et al.. (2004). Nucleoside Analogues and Mitochondrial Toxicity. Clinical Infectious Diseases. 38(8). e79–e80. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact